|
SRP9 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.11459763430366E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.65649716166172E-11 |
| Normal-vs-Stage2 |
1.211960E-02 |
| Normal-vs-Stage3 |
5.511299999994E-05 |
| Normal-vs-Stage4 |
3.181200E-01 |
| Stage1-vs-Stage2 |
3.369200E-01 |
| Stage1-vs-Stage3 |
7.144200E-01 |
| Stage1-vs-Stage4 |
6.496300E-02 |
| Stage2-vs-Stage3 |
6.217000E-01 |
| Stage2-vs-Stage4 |
4.537600E-01 |
| Stage3-vs-Stage4 |
1.862030E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.21049947843233E-10 |
| Normal-vs-AfricanAmerican |
1.25380000048914E-07 |
| Normal-vs-Asian |
1.820690E-04 |
| Caucasian-vs-AfricanAmerican |
9.041800E-01 |
| Caucasian-vs-Asian |
6.420400E-01 |
| AfricanAmerican-vs-Asian |
6.034600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.25537383108576E-12 |
| Normal-vs-Female |
6.16509999999959E-05 |
| Male-vs-Female |
3.826500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.2136999999468E-06 |
| Normal-vs-Extreme_Weight |
1.67049707400224E-11 |
| Normal-vs-Obese |
7.17629999980041E-07 |
| Normal-vs-Extreme_Obese |
2.562500E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.154200E-01 |
| Normal_Weight-vs-Obese |
9.474400E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.802000E-01 |
| Extreme_Weight-vs-Obese |
2.387200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.685200E-01 |
| Obese-vs-Extreme_Obese |
9.532800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.152180E-04 |
| Normal-vs-Age(41-60Yrs) |
1.51169998741096E-09 |
| Normal-vs-Age(61-80Yrs) |
2.46670017745032E-10 |
| Normal-vs-Age(81-100Yrs) |
1.82409999993638E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.848600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.988000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.339600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.962200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.704800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.863000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.00379737644607E-11 |
| Normal-VS-Type2 PRCC |
6.07799999219338E-09 |
| Normal-VS-KIRP CIMP |
1.139390E-01 |
| Normal-VS-Unclassified PRCC |
2.86920043279792E-10 |
| Type1 PRCC-VS-Type2 PRCC |
7.064200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.372600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.322000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.451200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.157600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.076000E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.63350008467E-10 |
| Normal-vs-N1 |
1.369570E-01 |
| Normal-vs-N2 |
2.224500E-02 |
| N0-vs-N1 |
8.236000E-02 |
| N0-vs-N2 |
3.942800E-01 |
| N1-vs-N2 |
7.487800E-01 |
|
|
